Cannabis and its effects on driving skills

Forensic Science International

Volumn 268, Issue , 2016, Pages 92-102

  Bondallaz, Percy ^a   Favrat, Bernard ^a,b   Chtioui, Haïthem ^c   Fornari, Eleonora ^c   Maeder, Philippe ^c   Giroud, Christian ^a  

^a UNIVERSITY CENTER OF LEGAL MEDICINE   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Cannabis; Driving; Fitness to drive; Psychomotor effects; THC

Indexed keywords

CANNABIS; DRONABINOL; MEDICAL CANNABIS;

ALCOHOL CONSUMPTION; BLOOD LEVEL; BLOOD SAMPLING; CANNABIS ADDICTION; CANNABIS USE; DRIVING ABILITY; HUMAN; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; REVIEW; COGNITION; COMPLICATION; DRINKING BEHAVIOR; DRUG EFFECTS; DRUG INTERACTION; DRUNKEN DRIVING; LEGISLATION AND JURISPRUDENCE; PUBLIC POLICY; SUBSTANCE ABUSE;

ALCOHOL DRINKING; COGNITION; DRIVING UNDER THE INFLUENCE; DRONABINOL; DRUG INTERACTIONS; HUMANS; MARIJUANA ABUSE; MARIJUANA USE; MEDICAL MARIJUANA; PSYCHOMOTOR PERFORMANCE; PUBLIC POLICY; SUBSTANCE ABUSE DETECTION;

EID: 84988973155     PISSN: 03790738     EISSN: 18726283     Source Type: Journal    
DOI: 10.1016/j.forsciint.2016.09.007     Document Type: Review

References (90)

1. [1] World Drug Report 2015, United Nations Office on Drugs and Crime., 2015, United Nations Publication, New York.
2. [2] Zalesky, A., Solowij, N., Yücel, M., et al. Effect of long-term cannabis use on axonal fibre connectivity. Brain 135 (2012), 2245–2255.
3. [3] Filbey, F., Yezhuvath, U., Functional connectivity in inhibitory control networks and severity of cannabis use disorder. Am. J. Drug Alcohol Abuse 39 (2013), 382–391.
4. [4] Le Strat, Y., Dubertret, C., Le Foll, B., Impact of age onset of cannabis use on cannabis dependence and driving under the influence in the United States. Accid. Anal. Prev. 76 (2015), 1–5.
5. [5] Walsh, J.M., Verstraete, A.G., Huestis, M.A., Morland, J., Guidelines for research on drugged driving. Addiction 103:8 (2008), 1258–1268.
6. [6] Pope, H.G. Jr., Yurgelun-Todd, D., The residual cognitive effects of heavy marijuana use in college students. JAMA 275 (1996), 521–527.
7. [7] Solowij, N., Marijuana Treatment Project Research Group, Cognitive functioning of long-term heavy cannabis users seeking treatment. JAMA 287 (2002), 1123–1131.
8. [8] Solowij, N., Battisti, R., The chronic effects of cannabis on memory in humans: a review. Curr. Drug Abuse Rev. 1 (2008), 81–98.
9. [9] Bolla, K.I., Brown, K., Eldreth, D., Tate, K., Cadet, J.L., Dose-related neurocognitive effects of marijuana use. Neurology 59 (2002), 1337–1343.
10. [10] Pope, H.G. Jr., Gruber, A.J., Hudson, J.I., Huestis, M.A., Yurgelun-Todd, D., Neuropsychological performance in long-term cannabis users. Arch. Gen. Psychiatry 58 (2001), 909–915.
11. [11] Pope, H.G. Jr., et al. Early-onset cannabis use and cognitive deficits: what is the nature of the association?. Drug Alcohol Depend. 69 (2003), 303–310.
12. [12] Driving under the influence of drugs, alcohol and medicines (DRUID), Cannabis, driving and road safety: a review of the scientific literature. Deliverable D2.1.3, 2011.
13. [13] Senna, M.C., Augsburger, M., Aebi, B., Briellmann, T.A., Donze, N., Dubugnon, J.L., Iten, P.X., Staub, C., Sturm, W., Sutter, K., First nationwide study on driving under the influence of drugs in Switzerland. Forensic Sci. Int. 198:1–3 (2010), 11–16.
14. [14] Asbridge, M., Hayden, J.A., Cartwright, J.L., Acute cannabis consumption and motor vehicle collision risk: systematic review of observational studies and meta-analysis. BMJ, 344, 2012, e536.
15. [15] Blows, S., Ivers, R.Q., Connor, J., Ameratunga, S., Woodward, M., Norton, R., Marijuana use and car crash injury. Addiction 100:5 (2005), 605–611.
16. [16] Moskowitz, H., Marihuana and driving. Accid. Anal. Prev. 17:4 (1985), 323–345.
17. [17] Rafaelsen, O.J., Bech, P., Christiansen, J., Christrup, H., Nyboe, J., Rafaelsen, L., Cannabis and alcohol: effects on stimulated car driving. Science 179:4076 (1973), 920–923.
18. [18] Smiley, A., Marijuana: on-road and driving simulator studies. Kalant, H., Corrigala, W., Hall, W., Smart, R.G., (eds.) The Health Effects of Cannabis, 1998, Centre for Addiction and Mental Health, Toronto, 173–191.
19. [19] Ward, N.J., Dye, L., Cannabis and Driving. A Review of the Literature and Commentary., 1999, Ed Department of the Environment, Transport and the Regions. London Road Safety Research Report no.12 94 p.
20. [20] Kurzthaler, I., Hummer, M., Miller, C., Sperner-Unterweger, B., Gunther, V., Wechdorn, H., Battista, H.-J., Fleischhacker, W.W., Effect of cannabis use on cognitive functions and driving ability. J. Clin. Psychiatry 60:6 (1999), 395–399.
21. [21] Robbe, H.W.J., Marijuana's impairing effects on driving are moderate when taken alone but severe when combined with alcohol. Hum. Psychopharmacol. Clin. Exp. 13 (1998), S70–S78.
22. [22] Sexton, B.F., Tunbridge, R.J., Brook-Carter, N., Jackson, P.G., Wright, K., Stark, M.M., Englehart, K., The influence of cannabis on driving. TRL Report, 477, 2000, 106p.
23. [23] Ramaekers, J.G., Kauert, G., van Ruitenbeek, P., Theunissen, E.L., Schneider, E., Moeller, M.R., High-potency marijuana impairs executive function and inhibitory motor control. Neuropsychopharmacology 31:10 (2006), 2296–2303.
24. [24] Lenne, M.G., Dietze, P.M., Triggs, T.J., Walmsley, S., Murphy, B., Redman, J.R., The effects of cannabis and alcohol on simulated arterial driving: influences of driving experience and task demand. Accid. Anal. Prev. 42:3 (2010), 859–866.
25. [25] Liguori, A., Gatto, C.P., Robinson, J.H., Effects of marijuana on equilibrium, psychomotor performance, and simulated driving. Behav. Pharmacol. 9:7 (1998), 599–609.
26. [26] MacDonald, J., Schleifer, L., Richards, J.B., de Wit, H., Effects of THC on behavioral measures of impulsivity in humans. Neuropsychopharmacology 28:7 (2003), 1356–1365.
27. [27] Ronen, A., Gershon, P., Drobiner, H., Rabinovich, A., Bar-Hamburger, R., Mechoulam, R., Cassuto, Y., Shinar, D., Effects of THC on driving performance, physiological state and subjective feelings relative to alcohol. Accid. Anal. Prev. 40:3 (2008), 926–934.
28. [28] Chait, L.D., Perry, J.L., Acute and residual effects of alcohol and marijuana, alone and in combination, on mood and performance. Psychopharmacology (Berl) 115:3 (1994), 340–349.
29. [29] Hart, C.L., van Gorp, W., Haney, M., Foltin, R.W., Fischman, M.W., Effects of acute smoked marijuana on complex cognitive performance. Neuropsychopharmacology 25:5 (2001), 757–765.
30. [30] Morrison, P.D., Zois, V., McKeown, D.A., Lee, T.D., Holt, D.W., Powell, J.F., Kapur, S., Murray, R.M., The acute effects of synthetic intravenous Delta9-tetrahydrocannabinol on psychosis, mood and cognitive functioning. Psychol. Med. 39:10 (2009), 1607–1616.
31. [31] Metrik, J., Kahler, C.W., Reynolds, B., McGeary, J.E., Monti, P.M., Haney, M., de Wit, H., Rohsenow, D.J., Balanced placebo design with marijuana: pharmacological and expectancy effects on impulsivity and risk taking. Psychopharmacology (Berl) 223:4 (2012), 489–499.
32. [32] Weinstein, A., Brickner, O., Lerman, H., Greemland, M., Bloch, M., Lester, H., Chisin, R., Sarne, Y., Mechoulam, R., Bar-Hamburger, R., Freedman, N., Even-Sapir, E., A study investigating the acute dose-response effects of 13 mg and 17 mg Delta 9-tetrahydrocannabinol on cognitive-motor skills, subjective and autonomic measures in regular users of marijuana. J. Psychopharmacol. 22:4 (2008), 441–451.
33. [33] Ramaekers, J.G., Kauert, G., Theunissen, E.L., Toennes, S.W., Moeller, M.R., Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users. J. Psychopharmacol. 23:3 (2009), 266–277.
34. [34] Ramaekers, J.G., Theunissen, E.L., de Brouwer, M., Toennes, S.W., Moeller, M.R., Kauert, G., Tolerance and cross-tolerance to neurocognitive effects of THC and alcohol in heavy cannabis users. Psychopharmacology (Berl) 214:2 (2011), 391–401.
35. [35] Schwope, D.M., Bosker, W.M., Ramaekers, J.G., Gorelick, D.A., Huestis, M.A., Psychomotor performance, subjective and physiological effects and whole blood Delta(9)-tetrahydrocannabinol concentrations in heavy, chronic cannabis smokers following acute smoked cannabis. J. Anal. Toxicol. 36:6 (2012), 405–412.
36. [36] Sewell, R.A., Schnakenberg, A., Elander, J., Radhakrishnan, R., Williams, A., Skosnik, P.D., Pittman, B., Ranganathan, M., D'Souza, D.C., Acute effects of THC on time perception in frequent and infrequent cannabis users. Psychopharmacology (Berl) 226:2 (2013), 401–413.
37. [37] Lane, S.D., Cherek, D.R., Tcheremissine, O.V., Lieving, L.M., Pietras, C.J., Acute marijuana effects on human risk taking. Neuropsychopharmacology 30:4 (2005), 800–809.
38. [38] Vadhan, N.P., Hart, C.L., van Gorp, W.G., Gunderson, E.W., Haney, M., Foltin, R.W., Acute effects of smoked marijuana on decision making, as assessed by a modified gambling task, in experienced marijuana users. J. Clin. Exp. Neuropsychol. 29 (2007), 357–364.
39. [39] Weinstein, A., Brickner, O., Lerman, H., Greemland, M., Bloch, M., Lester, H., Chisin, R., Mechoulam, R., Bar-Hamburger, R., Freedman, N., Even-Sapir, E., Brain imaging study of the acute effects of Delta9-tetrahydrocannabinol (THC) on attention and motor coordination in regular users of marijuana. Psychopharmacology (Berl) 196:1 (2008), 119–131.
40. [40] Battistella, G., Fornari, E., Thomas, A., Mall, J.F., Chtioui, H., Appenzeller, M., Annoni, J.-M., Favrat, B., Maeder, P., Giroud, C., Weed or wheel! FMRI, behavioural, and toxicological investigations of how cannabis smoking affects skills necessary for driving. PLoS One, 8(1), 2013, e52545.
41. [41] Theunissen, E.L., Kauert, G.F., Toennes, S.W., Moeller, M.R., Sambeth, A., Blanchard, M.M., Ramaekers, J.G., Neurophysiological functioning of occasional and heavy cannabis users during THC intoxication. Psychopharmacology (Berl) 220:2 (2012), 341–350.
42. [42] Veldstra, J.L., Bosker, W.M., de Waard, D., Ramaekers, J.G., Brookhuis, K.A., Comparing treatment effects of oral THC on simulated and on-the-road driving performance: testing the validity of driving simulator drug research. Psychopharmacology 232 (2015), 2911–2919.
43. [43] Ménétrey, A., Augsburger, M., Favrat, B., Pin, M.A., Rothuizen, L.E., Appenzeller, M., Buclin, T., Mangin, P., Giroud, C., Assessment of driving capability through the use of clinical and psychomotor tests in relation to blood cannabinoids levels following oral administration of 20 mg dronabinol or of a cannabis decoction made with 20 or 60 mg Delta9-THC. J. Anal. Toxicol. 29:5 (2005), 327–338.
44. [44] Ronen, A., Chassidim, H.S., Gershon, P., Parmet, Y., Rabinovich, A., Bar-Hamburger, R., Cassuto, Y., Shinar, D., The effect of alcohol, THC and their combination on perceived effects, willingness to drive and performance of driving and non-driving tasks. Accid. Anal. Prev. 42:6 (2010), 1855–1865.
45. [45] Anderson, B.M., Rizzo, M., Block, R.I., Pearlson, G.D., O'Leary, D.S., Sex differences in the effects of marijuana on simulated driving performance. J. Psychoactive Drugs 42:1 (2010), 19–30.
46. [46] Ramaekers, J.G., Robbe, H.W., O'Hanlon, J.F., Marijuana, alcohol and actual driving performance. Hum. Psychopharmacol. 15:7 (2000), 551–558.
47. [47] Robbe, H.W.J., O'Hanlon, J.F., Marijuana, Alcohol and Actual Driving Performance. Report DOT HS 808 939., 1999, National Highway Traffic Safety Administration, Washington DC, 1–43.
48. [48] Sewell, R.A., Poling, J., Sofuoglu, M., The effect of cannabis compared with alcohol on driving. Am. J. Addict. 18:3 (2009), 185–193.
49. [49] Pulido, J., Barrio, G., Lardelli, P., Bravo, M.J., Brugal, M.T., Espelt, A., de la Fuente, L., Ambros, M., Belza, M.J., Castellano, Y., Domingo-Salvany, A., Fernandez, F., Molist, G., Sanchez-Niubo, A., Santos, S., Sordo, L., Vallejo, F., Cannabis use and traffic injuries. Epidemiology 22:4 (2011), 609–610.
50. [50] Liguori, A., Gatto, C.P., Jarrett, D.B., Separate and combined effects of marijuana and alcohol on mood, equilibrium and simulated driving. Psychopharmacology 163 (2002), 399–405.
51. [51] Bramness, J.G., Khiabani, H.Z., Morland, J., Impairment due to cannabis and ethanol: clinical signs and additive effects. Addiction 105:6 (2010), 1080–1087.
52. [52] Downey, L.A., King, R., Papafotiou, K., Swann, P., Ogden, E., Boorman, M., Stough, C., The effects of cannabis and alcohol on simulated driving: influences of dose and experience. Accid. Anal. Prev. 50 (2013), 879–886.
53. [53] Hartman, R.L., Brown, L.B., Milavetz, G., Spurgin, A., Pierce, R.S., Gorelick, D.A., Gaffney, G., Huestis, M.A., Cannabis effects on driving lateral control with and without alcohol. Drug Alcohol Depend. 154 (2015), 25–37.
54. [54] Dubois, S., Mullen, N., Weaver, B., Bédard, M., The combined effects of alcohol and cannabis on driving: impact on crash risk. Forensic Sci. Int. 248 (2015), 94–100.
55. [55] Hartman, R.L., Brown, T.L., Milavetz, G., Spurgin, A., Pierce, R.S., Gorelick, D.A., Gaffney, G., Huestis, M.A., Cannabis effects on driving longitudinal control with and without alcohol. J. Appl. Toxicol., 18, 2016.
56. [56] Neavyn, M.J., Blohm, E., Babu, K.M., Bird, S.B., Medical marijuana and driving: a review. J. Med. Toxicol. 10 (2014), 269–279.
57. [57] Salomonsen-Sautel, S., Min, S.-J., Sakai, J.T., Thurstone, C., Hopfer, C., Trends in fatal motor vehicle crashes before and after marijuana commercialization in Colorado. Drug Alcohol Depend. 140 (2014), 137–144.
58. [58] Hall, W., Solowij, N., Adverse effects of cannabis. Lancet 352:9140 (1998), 1611–1616.
59. [59] Pope, H.G. Jr., Gruber, A.J., Hudson, J.I., Huestis, M.A., Yurgelun-Todd, D., Cognitive measures in long-term cannabis users. J. Clin. Pharmacol. 42:11 Suppl (2002), 41s–47s.
60. [60] Bolla, K.I., Eldreth, D.A., Matochik, J.A., Cadet, J.L., Neural substrates of faulty decision-making in abstinent marijuana users. Neuroimage 26:2 (2005), 480–492.
61. [61] Verdejo-Garcia, A.J., Lopez-Torrecillas, F., Aguilar de Arcos, F., Perez-Garcia, M., Differential effects of MDMA, cocaine, and cannabis use severity on distinctive components of the executive functions in polysubstance users: a multiple regression analysis. Addict. Behav. 30:1 (2005), 89–101.
62. [62] Crean, R.D., Crane, N.A., Mason, B.J., An evidence based review of acute and long-term effects of cannabis use on executive cognitive functions. J. Addict. Med. 5:1 (2011), 1–8.
63. [63] Lyons, M.J., Bar, J.L., Panizzon, M.S., Toomey, R., Eisen, S., Xian, H., Tsuang, M.T., Neuropsychological consequences of regular marijuana use: a twin study. Psychol. Med. 34:7 (2004), 1239–1250.
64. [64] Verdejo-Garcia, A., Rivas-Perez, C., Lopez-Torrecillas, F., Perez-Garcia, M., Differential impact of severity of drug use on frontal behavioral symptoms. Addict. Behav. 31:8 (2006), 1373–1382.
65. [65] Whitlow, C.T., Liguori, A., Livengood, L.B., Hart, S.L., Mussat-Whitlow, B.J., Lamborn, C.M., Laurienti, P.J., Porrino, L.J., Long-term heavy marijuana users make costly decisions on a gambling task. Drug Alcohol Depend. 76:1 (2004), 107–111.
66. [66] Solowij, N., Do cognitive impairments recover following cessation of cannabis use?. Life Sci. 56:23–24 (1995), 2119–2126.
67. [67] Bosker, W.M., Karschner, E.L., Lee, D., Goodwin, R.S., Hirvonen, J., Innis, R.B., Theunissen, E.L., Kuypers, K.P.C., Huestis, M.A., Ramaekers, J.G., Psychomotor function in chronic daily Cannabis smokers during sustained abstinence. PLoS One, 8(1), 2013, e53127.
68. [68] Kelleher, L.M., Stough, C., Sergejew, A.A., Rolfe, T., The effects of cannabis on information-processing speed. Addict. Behav. 29:6 (2004), 1213–1219.
69. [69] Hirvonen, J., In vivo imaging of the cannabinoid CB1 receptor with positron emission tomography. Clin. Pharmacol. Ther. 97:6 (2015), 565–567.
70. [70] Battistella, G., Fornari, E., Annoni, J.-M., Chtioui, H., Dao, K., Fabritius, M., Favrat, B., Mall, J.F., Maeder, P., Giroud, C., Long-term effects of cannabis on brain structure. Neuropsychopharmacology 39:9 (2014), 2041–2048.
71. [71] Mura, P., Kintz, P., Dumestre, V., Raul, S., Hauet, T., THC can be detected in brain while absent in blood. J. Anal. Toxicol. 29:8 (2005), 842–843.
72. [72] Huestis, M.A., Barnes, A., Smith, M.L., Estimating the time of last cannabis use from plasma delta9-tetrahydrocannabinol and 11-nor-9-carboxy-delta9-tetrahydrocannabinol concentrations. Clin. Chem. 51:12 (2005), 2289–2295.
73. [73] Hartman, R.L., Brown, T.L., Milavetz, G., Spurgin, A., Gorelick, D.A., Gaffney, G.R., Huestis, M.A., Effect of blood collection time on measured 9-tetrahydrocannabinol concentrations: implications for driving interpretation and drug policy. Clin. Chem. 62:2 (2016), 367–377.
74. [74] Bergamaschi, M.M., Karschner, E.L., Goodwin, R.S., Scheidweiler, K.B., Hirvonen, J., Queiroz, R.H., Huestis, M.A., Impact of prolonged cannabinoid excretion in chronic daily cannabis smokers’ blood on per se drugged driving laws. Clin. Chem. 59:3 (2013), 519–526.
75. [75] Desrosiers, N.A., Himes, S.K., Scheidweiler, K.B., Concheiro-Guisan, M., Gorelick, D.A., Huestis, M.A., Phase I and II cannabinoid disposition in blood and plasma of occasional and frequent smokers following controlled smoked cannabis. Clin. Chem. 60:4 (2014), 631–643.
76. [76] Mareck, U., Haenelt, N., Geyer, H., Guddat, S., Kamber, M., Brenneisen, R., Thevis, M., Schänzer, W., Temporal indication of cannabis use by means of THC glucuronide determination. Drug Test. Anal. 1:11–12 (2009), 505–510.
77. [77] Verstraete, A., Knoche, A., Jantos, R., Skopp, G., Gjerde, H., Vindenes, V., Morland, J., Langel, K., Lillsunde, P., Per se Limits—Methods of Defining Cut-off Values for Zero Tolerance. 2011, Driving Under the Influence of Drugs, Alcohol and Medicines (DRUID) Deliverable D1.4.2.
78. [78] Lee, D., Huestis, M.A., Current knowledge on cannabinoids in oral fluid. Drug Test. Anal. 6:1–2 (2014), 88–111.
79. [79] Desrosiers, N.A., Milman, G., Mendu, D.R., Lee, D., Barnes, A.J., Gorelick, D.A., Huestis, M.A., Cannabinoids in oral fluid by on-site immunoassay and by GC–MS using two different oral fluid collection devices. Anal. Bioanal. Chem. 406:17 (2014), 4117–4128.
80. [80] Fabritius, M., Favrat, B., Chtioui, H., Battistella, G., Annoni, J.M., Appenzeller, M., Dao, K., Fornari, E., Lauer, E., Mall, J.-F., Maeder, P., Mangin, P., Staub, C., Giroud, C., THCCOOH concentrations in whole blood: are they useful in discriminating occasional from heavy smokers?. Drug Test. Anal. 6:1–2 (2014), 155–163.
81. [81] Papafotiou, K., Carter, J.D., Stough, C., The relationship between performance on the standardised field sobriety tests, driving performance and the level of Delta9-tetrahydrocannabinol (THC) in blood. Forensic Sci. Int. 155:2–3 (2005), 172–178.
82. [82] Bosker, W.M., Kuypers, K.P., Theunissen, E.L., Surinx, A., Blankespoor, R.J., Skopp, G., Jeffery, W.K., Walls, H.C., van Leeuwen, C.J., Ramaekers, J.G., Medicinal Delta(9)-tetrahydrocannabinol (dronabinol) impairs on-the-road driving performance of occasional and heavy cannabis users but is not detected in Standard Field Sobriety Tests. Addiction 107:10 (2012), 1837–1844.
83. [83] Bosker, W.M., Theunissen, E.L., Conen, S., Kuypers, K.P., Jeffery, W.K., Walls, H.C., Kauert, G.F., Toennes, S.W., Moeller, M.R., Ramaekers, J.G., A placebo-controlled study to assess Standardized Field Sobriety Tests performance during alcohol and cannabis intoxication in heavy cannabis users and accuracy of point of collection testing devices for detecting THC in oral fluid. Psychopharmacology (Berl) 223:4 (2012), 439–446.
84. [84] Downey, L.A., King, R., Papafotiou, K., Swann, P., Ogden, E., Boorman, M., Stough, C., Detecting impairment associated with cannabis with and without alcohol on the Standardized Field Sobriety Tests. Psychopharmacology (Berl) 224:4 (2012), 581–589.
85. [85] Porath-Waller, A.J., Beirness, D.J., An examination of the validity of the standardized field sobriety test in detecting drug impairment using data from the Drug Evaluation and Classification program. Traffic Inj. Prev. 15:2 (2014), 125–131.
86. [86] Ramaekers, J.G., Berghaus, G., van Laar, M., Drummer, O.H., Dose related risk of motor vehicle crashes after cannabis use. Drug Alcohol Depend. 73:2 (2004), 109–119.
87. [87] Ramaekers, J.G., Berghaus, G., van Laar, M.W., Drummer, O.H., Dose related risk of motor vehicle crashes after cannabis use: an update. Verster, J.C., Pandi-Perumai, D.R., Ramaekers, J.G., de Gier, J.J., (eds.) Drugs, Driving, and Traffic Safety, 2010, Birkhauser, Basel, 501–518.
88. [88] Armentano, P., Should per se limits be imposed for cannabis? Equating cannabinoid blood concentrations with actual driver impairment: practical limitations and concerns. Humboldt J. Soc. Relat. 35 (2013), 41–51.
89. [89] Wong, K., Brady, J.E., Li, G., Establishing legal limits for driving under the influence of marijuana. Inj. Epidemiol., 1, 2014, 26.
90. [90] Giroud, C., Menetrey, A., Augsburger, M., Buclin, T., Sanchez-Mazas, P., Mangin, P., Delta(9)-THC, 11-OH-Delta(9)-THC and Delta(9)-THCCOOH plasma or serum to whole blood concentrations distribution ratios in blood samples taken from living and dead people. Forensic Sci. Int. 123:2–3 (2001), 159–164.